Novo Nordisk A/S vs TKO Group Holdings Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: Novo Nordisk A/S is far larger — about 16.1× TKO Group Holdings Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | TKO | |
|---|---|---|
Market Cap | $220.53B | $13.70B |
Sector | Health | Technology |
52-Week High | $71.70 | $224.96 |
52-Week Low | $35.29 | $155.61 |
Enterprise Value | $239.49B | $17.88B |
Dividend Yield | 3.63% | 1.7% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →